Accretion / Dilution Analysis

The three sources are cash, debt, and stock. Cash is generally the cheapest because its opportunity cost is just the foregone post-tax interest income on cash balances. Debt is the next cheapest due to tax-deductible interest expenses. Stock is almost always the most expensive because equity investors demand a higher rate of return, and issuing new shares directly dilutes existing owners.

In an all-stock deal, if the acquirer's P/E ratio is higher than the target's P/E ratio, the acquisition will be accretive. If the acquirer's P/E ratio is lower than the target's P/E ratio, the deal will be dilutive. This rule assumes no synergies and no transactional fees, reflecting the basic ratio of earnings purchased per share issued.

The deal is accretive. Because the acquirer has a higher P/E multiple than the target, it is deploying high-valued equity to purchase a larger stream of earnings relatively cheaply. This increases the total combined earnings per share.

Synergies represent cost savings or revenue upside generated by combining the two businesses. Cost synergies (such as head-count reduction or office consolidation) directly increase pro-forma net income, making a transaction more accretive or less dilutive. Revenue synergies do the same but are typically heavily discounted by analysts due to execution risk.

A company might pursue a dilutive deal if there are compelling strategic reasons, such as acquiring critical intellectual property, entering a fast-growing new geography, or capturing massive long-term revenue synergies that will eventually turn the deal accretive in later years.

Not necessarily. Accretion is an accounting metric focused on short-term EPS. A deal can be accretive on paper due to financing structures or financial engineering while destroying strategic value if the integration fails or the purchase price was too high.

An asset write-up creates new intangible assets on the balance sheet, which leads to increased non-cash amortisation expenses. This post-tax amortisation reduces pro-forma net income and makes the deal less accretive or more dilutive.

GAAP EPS includes non-cash items like the amortisation of acquired intangibles. Cash EPS adds back these non-cash amortisation charges. Many investment bankers look at Cash EPS accretion because it isolates the actual cash-flow generation capability of the deal.

Yes. The P/E rule of thumb only applies strictly to 100% stock transactions. If a deal is financed with debt, it will be accretive as long as the target's earnings yield (the inverse of its P/E) is higher than the post-tax cost of that debt.

Advisory and legal fees are typically expensed immediately at the close of the transaction, which reduces pro-forma net income in the first year. Financing fees are capitalised and amortised over the life of the debt, creating an ongoing non-cash expense.

The exchange ratio dictates how many shares of the acquirer's stock are offered for each individual share of the target company's stock. It is calculated by dividing the offer price per target share by the current market price per acquirer share.

Investors may look past the immediate accounting accretion and penalise the acquirer if they believe the strategic rationale is weak, the integration risk is too high, or the company took on excessive leverage to force the deal to look accretive.